Boorjian SA - Search Results

1

Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS. Raman JD, et al. Among authors: boorjian sa. BJU Int. 2005 Nov;96(7):1031-5. doi: 10.1111/j.1464-410X.2005.05804.x. BJU Int. 2005. PMID: 16225523

2

Right laparoscopic live donor nephrectomy: a single institution experience.

Boorjian S, Munver R, Sosa RE, Del Pizzo JJ. Boorjian S, et al. Transplantation. 2004 Feb 15;77(3):437-40. doi: 10.1097/01.TP.0000113230.90613.47. Transplantation. 2004. PMID: 14966422

3

Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.

Boorjian S, Tickoo SK, Mongan NP, Yu H, Bok D, Rando RR, Nanus DM, Scherr DS, Gudas LJ. Boorjian S, et al. Clin Cancer Res. 2004 May 15;10(10):3429-37. doi: 10.1158/1078-0432.CCR-03-0756. Clin Cancer Res. 2004. PMID: 15161698

4

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Boorjian S, et al. Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025. Urology. 2004. PMID: 15302512

5

Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.

Boorjian S, Ng C, Munver R, Palese MA, Sosa RE, Vaughan ED, Del Pizzo JJ, Scherr DS. Boorjian S, et al. J Endourol. 2004 Nov;18(9):912-6. doi: 10.1089/end.2004.18.912. J Endourol. 2004. PMID: 15659932

6

Retinoid receptor mRNA expression profiles in human bladder cancer specimens.

Boorjian S, Scherr DS, Mongan NP, Zhuang Y, Nanus DM, Gudas LJ. Boorjian S, et al. Int J Oncol. 2005 Apr;26(4):1041-8. Int J Oncol. 2005. PMID: 15754000

7

Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.

Boorjian S, Ng C, Munver R, Palese MA, Vaughan ED Jr, Sosa RE, Del Pizzo JJ, Scherr DS. Boorjian S, et al. Urology. 2005 Aug;66(2):283-7. doi: 10.1016/j.urology.2005.02.022. Urology. 2005. PMID: 16098357

8

Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?

Boorjian SA, Bianco FJ Jr, Scardino PT, Eastham JA. Boorjian SA, et al. BJU Int. 2005 Oct;96(6):773-6. doi: 10.1111/j.1464-410X.2005.05763.x. BJU Int. 2005. PMID: 16153197

9

Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.

Barocas DA, Kawamoto H, Dreizin DF, Howard ME, Choi J, Pitts WR, You X, Tickoo SK, Boorjian SA, Scherr DS. Barocas DA, et al. Among authors: boorjian sa. Urology. 2005 Nov;66(5):1134-9. doi: 10.1016/j.urology.2005.06.079. Urology. 2005. PMID: 16286153

10

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.

Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: boorjian sa. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6. doi: 10.1158/1078-0432.CCR-05-1047. Clin Cancer Res. 2005. PMID: 16361539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters